Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) is an FDA-approved injectable medication for chronic weight management, but obtaining it involves navigating prescriptions, insurance, and supply constraints. PlexusDx offers compounded semaglutide from licensed 503A pharmacies as a flexible alternative that serves all 50 states without insurance requirements. Understanding your prescription options helps you choose the right path for your weight loss goals.

Understanding Wegovy Prescription Requirements

Wegovy requires a valid prescription from a licensed physician, nurse practitioner, or physician assistant. The prescriber must evaluate your medical history, current medications, and weight loss goals to determine if semaglutide is appropriate for you. Insurance coverage varies significantly by plan, with many carriers requiring prior authorization or imposing strict eligibility criteria based on BMI thresholds.

The prescription process typically involves an initial consultation, baseline health assessments, and ongoing monitoring for side effects and efficacy. Brand-name Wegovy availability has faced supply challenges, leading to extended waitlists at some pharmacies and telemedicine platforms. Cost for insured patients ranges from modest copays to several hundred dollars monthly, depending on coverage details.

How Compounded Semaglutide Differs From Wegovy

Compounded semaglutide is prepared by licensed 503A compounding pharmacies under pharmacy oversight rather than manufactured by a pharmaceutical company. While compounded medications are not FDA-approved in the same way brand products are, they follow rigorous quality, sterility, and potency standards established by the FDA and U.S. Pharmacopeia. Compounded semaglutide delivers the same active ingredient at a predictable monthly cost without insurance gatekeeping.

PlexusDx sources all compounded medications exclusively from licensed 503A pharmacies, never from 503B facilities. Patients receive the same GLP-1 mechanism of action—slowing gastric emptying and enhancing satiety—but with pricing transparency and accessibility across all 50 states. The primary difference is the sourcing pathway, not the clinical mechanism or patient outcomes.

Prescription Requirements for PlexusDx Compounded Semaglutide

PlexusDx requires a valid prescription from your primary care physician, a telemedicine provider, or another licensed prescriber. You maintain control over your prescriber relationship—you can use your own doctor or connect with PlexusDx partner clinicians who specialize in GLP-1 therapy. The prescription process is streamlined to minimize delays, with support from PlexusDx clinical staff to facilitate communication between you and your prescriber.

Once you have a prescription, PlexusDx handles medication delivery directly to your home. No membership fees, no insurance requirements, and HSA/FSA funds are eligible for payment. Your dose may need to go up as your body adapts, but your monthly price stays flat—starting at $149 per month for compounded semaglutide injection across all commitment tiers.

Personalization With Genetic Testing for GLP-1 Success

Not every GLP-1 medication works equally for every patient due to genetic variation in appetite-regulating pathways. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway test (not pharmacogenomic)—that maps 14 signaling pathways, 49 peptides, and 150+ genetic insights. Key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 influence how your body responds to semaglutide, tirzepatide, and dual-compound therapy.

This genetic data helps PlexusDx clinicians predict which medication—oral semaglutide, injection, tirzepatide, or the GLP-Squared dual compound—aligns best with your genetic predispositions. The test is available as a $99 add-on after your first month of treatment, giving you time to assess tolerance before pursuing deeper personalization. Patients with specific genetic profiles may achieve better results and fewer side effects with a customized approach.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a Wegovy prescription specifically, or can any semaglutide prescription work?

Any semaglutide prescription written by a licensed provider is valid. PlexusDx accepts prescriptions for compounded semaglutide, which is clinically equivalent to Wegovy. Your prescriber does not need to write 'Wegovy' specifically—they can prescribe 'semaglutide injection' at the dose and frequency you need.

What clinical evidence supports compounded semaglutide for weight loss?

Semaglutide—whether brand or compounded—works through GLP-1 receptor activation, a mechanism validated in multiple trials showing average weight loss of 10-15% over 68 weeks. Compounded formulations use the same active pharmaceutical ingredient and deliver comparable clinical outcomes when sourced from licensed 503A pharmacies.

How much does PlexusDx compounded semaglutide cost compared to Wegovy?

PlexusDx compounded semaglutide injection starts at $149 per month flat, with no insurance required and HSA/FSA eligibility. Wegovy through insurance or retail can range from $50 copays (with coverage) to $900+ monthly out-of-pocket. PlexusDx pricing remains constant regardless of dose increases.

Are there any safety or quality differences between Wegovy and compounded semaglutide?

Both contain identical semaglutide active ingredients and work through the same biological pathways. Compounded semaglutide from licensed 503A pharmacies follows FDA sterility and potency standards. Side effects—nausea, vomiting, constipation—are comparable across formulations and typically diminish as your body adapts.

How can the Precision Peptide Genetic Test help me choose between semaglutide and other GLP-1s?

The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, predicting whether semaglutide, tirzepatide, or dual GLP-Squared therapy will work best for your metabolism. This personalization reduces trial-and-error and can improve weight loss outcomes. The $99 test is available after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves